QIAGEN N.V. to release results for Q4 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) plans to release results for the fourth quarter and full year 2023 on Tuesday, February 6, after 22:05 Frankfurt time. The conference call is scheduled for Wednesday, February 7, at 15:00 Frankfurt time. Investors and analysts can join the call through various options, including call back connection, dial-in by phone, and access to the audio webcast.
01/11/2024 - 07:53 AM
Venlo, The Netherlands, Jan. 11, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter and full year 2023.
Press release date/time: Tuesday, February 6, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.
Conference call date/time: Wednesday, February 7, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.
Three options for joining the conference call
Register for call back connection - Click here: Connect me
Service is available 15 minutes before the call starts
Dial-in by phone
U.S.: +1 646 828 8193 UK: +44 (0)330 165 3655 GER: +49 (0)69 6610 2492 Conference ID: 2206067 To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
Access the audio webcast - Click here: Access Webcast
A conference call replay will be available by using the following link:https://event.webcasts.com/starthere.jsp?ei=1643464&tp_key=a2e231b651
Contact : IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of September 30, 2023, QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com .
source: QIAGEN N.V. category: Financial
When will QIAGEN N.V. release results for the fourth quarter and full year 2023?
QIAGEN N.V. will release the results on Tuesday, February 6, after 22:05 Frankfurt time.
When is the conference call scheduled for QIAGEN N.V.?
The conference call is scheduled for Wednesday, February 7, at 15:00 Frankfurt time.
How can investors and analysts join the conference call for QIAGEN N.V.?
Investors and analysts can join the call through various options, including call back connection, dial-in by phone, and access to the audio webcast.
QGEN Rankings
#3158 Ranked by Stock Gains
QGEN Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
Netherlands
City
Venlo
About QGEN
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. automation solutions tie these together in seamless and cost-effective molecular testing workflows. qiagen provides these workflows to more than 500,000 customers around the world in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing and food safety), pharma (pharmaceutical and biotechnology companies) and academia (life sciences research). as of june 30, 2015, qiagen employed approximately 4,400 people in over 35 locations worldwide. further information can be found at http://www.qiagen.com.